Vuletic, Ana

Link to this page

Authority KeyName Variants
006a1ec4-58f8-402b-9641-f74cafc45ffb
  • Vuletic, Ana (1)
Projects

Author's Bibliography

Detection of humoral and cellular immune response to anti-SARS-CoV-2 BNT162b2 vaccine in breastfeeding women and naïve and previously infected individuals

Cavic, Milena; Nešić, Andrijana N.; Mirjacic Martinovic, Katarina; Vuletic, Ana; Besu Zizak, Irina; Tisma Miletic, Nevena; Krivokuca, Ana; Jankovic, Radmila; Gavrović-Jankulović, Marija

(Nature Research, 2023)

TY  - JOUR
AU  - Cavic, Milena
AU  - Nešić, Andrijana N.
AU  - Mirjacic Martinovic, Katarina
AU  - Vuletic, Ana
AU  - Besu Zizak, Irina
AU  - Tisma Miletic, Nevena
AU  - Krivokuca, Ana
AU  - Jankovic, Radmila
AU  - Gavrović-Jankulović, Marija
PY  - 2023
UR  - http://cherry.chem.bg.ac.rs/handle/123456789/6247
AB  - This study explored humoral and cellular responses to anti-SARS-CoV-2 BNT162b2 mRNA vaccine in breastfeeding women and naïve and seropositive individuals in the first six months after vaccination.Sixty-one volunteers vaccinated with two doses of the BNT162b2 mRNA vaccine were enrolled in the study. In-house developed ELISA was used for the quantification of SARS-CoV-2 RBD-specific antibodies. Cell surface marker expression and intracellular IFN-γ analysis were carried out by flow cytometry. The concentrations of IFN-γ, IL-6 and TNF were determined by ELISA. A significant rise in anti-RBD IgG antibody levels was observed 14 days after the first vaccine dose (p < 0.0001) in serum and milk. The expression of CD28 on CD4+ T cells was significantly higher compared to baseline (p < 0.05). There was a significant increase (p ≤ 0.05) in B cell lymphocyte subset after revaccination, and increased percentage of CD80+ B cells. The expression of IFN-γ in peripheral blood lymphocytes, CD3+ T cells and serum was significantly increased (p < 0.05). No significant difference in immune response was observed between breastfeeding women and other study participants. The anti-SARS-CoV-2 BNT162b2 mRNA vaccine-induced measurable and durable immune response in breastfeeding women and in naïve and previously infected individuals.
PB  - Nature Research
T2  - Scientific Reports
T1  - Detection of humoral and cellular immune response to anti-SARS-CoV-2 BNT162b2 vaccine in breastfeeding women and naïve and previously infected individuals
VL  - 13
IS  - 1
SP  - 6271
DO  - 10.1038/s41598-023-33516-1
ER  - 
@article{
author = "Cavic, Milena and Nešić, Andrijana N. and Mirjacic Martinovic, Katarina and Vuletic, Ana and Besu Zizak, Irina and Tisma Miletic, Nevena and Krivokuca, Ana and Jankovic, Radmila and Gavrović-Jankulović, Marija",
year = "2023",
abstract = "This study explored humoral and cellular responses to anti-SARS-CoV-2 BNT162b2 mRNA vaccine in breastfeeding women and naïve and seropositive individuals in the first six months after vaccination.Sixty-one volunteers vaccinated with two doses of the BNT162b2 mRNA vaccine were enrolled in the study. In-house developed ELISA was used for the quantification of SARS-CoV-2 RBD-specific antibodies. Cell surface marker expression and intracellular IFN-γ analysis were carried out by flow cytometry. The concentrations of IFN-γ, IL-6 and TNF were determined by ELISA. A significant rise in anti-RBD IgG antibody levels was observed 14 days after the first vaccine dose (p < 0.0001) in serum and milk. The expression of CD28 on CD4+ T cells was significantly higher compared to baseline (p < 0.05). There was a significant increase (p ≤ 0.05) in B cell lymphocyte subset after revaccination, and increased percentage of CD80+ B cells. The expression of IFN-γ in peripheral blood lymphocytes, CD3+ T cells and serum was significantly increased (p < 0.05). No significant difference in immune response was observed between breastfeeding women and other study participants. The anti-SARS-CoV-2 BNT162b2 mRNA vaccine-induced measurable and durable immune response in breastfeeding women and in naïve and previously infected individuals.",
publisher = "Nature Research",
journal = "Scientific Reports",
title = "Detection of humoral and cellular immune response to anti-SARS-CoV-2 BNT162b2 vaccine in breastfeeding women and naïve and previously infected individuals",
volume = "13",
number = "1",
pages = "6271",
doi = "10.1038/s41598-023-33516-1"
}
Cavic, M., Nešić, A. N., Mirjacic Martinovic, K., Vuletic, A., Besu Zizak, I., Tisma Miletic, N., Krivokuca, A., Jankovic, R.,& Gavrović-Jankulović, M.. (2023). Detection of humoral and cellular immune response to anti-SARS-CoV-2 BNT162b2 vaccine in breastfeeding women and naïve and previously infected individuals. in Scientific Reports
Nature Research., 13(1), 6271.
https://doi.org/10.1038/s41598-023-33516-1
Cavic M, Nešić AN, Mirjacic Martinovic K, Vuletic A, Besu Zizak I, Tisma Miletic N, Krivokuca A, Jankovic R, Gavrović-Jankulović M. Detection of humoral and cellular immune response to anti-SARS-CoV-2 BNT162b2 vaccine in breastfeeding women and naïve and previously infected individuals. in Scientific Reports. 2023;13(1):6271.
doi:10.1038/s41598-023-33516-1 .
Cavic, Milena, Nešić, Andrijana N., Mirjacic Martinovic, Katarina, Vuletic, Ana, Besu Zizak, Irina, Tisma Miletic, Nevena, Krivokuca, Ana, Jankovic, Radmila, Gavrović-Jankulović, Marija, "Detection of humoral and cellular immune response to anti-SARS-CoV-2 BNT162b2 vaccine in breastfeeding women and naïve and previously infected individuals" in Scientific Reports, 13, no. 1 (2023):6271,
https://doi.org/10.1038/s41598-023-33516-1 . .
11
1
1
1